Dermatologic, Cosmeceutic, and Cosmetic Development: Therapeutic and Novel ApproachesKenneth A. Walters, Michael S. Roberts CRC Press, 13 dic 2007 - 648 páginas Recent advances in our understanding of the development and morphology of normal skin have led to improved methods to deliver therapeutic compounds to targeted areas both within the skin and systemically. This reference provides a clear overview of pharmaceutical and cosmetic practices, drugs, and therapies to manage and treat major and minor skin disorders. It examines the efficiency and delivery of topical therapies and explains how percutaneous absorption is affected by age, skin, site, race, skin disease, and damage and product form. Particular emphasis is on novel treatment approaches for major skin diseases and injuries pertaining to wounds and burns. |
Índice
| 1 | |
| 11 | |
| 21 | |
Chapter 4 Evolution of Cosmeceuticals and Their Application to Skin Disorders Including Aging and Blemishes | 45 |
Chapter 5 Biology of Skin Pigmentation and Cosmetic Skin Color Control | 61 |
Chapter 6 EvidenceBased Cosmeceutical Therapy | 97 |
Specific Factors Affecting Targeting and Efficacy | 115 |
Host and Environmental Factors | 129 |
Chapter 21 Dry Skin and Moisturizers | 339 |
Dermatological and Cosmeceutical Aspects | 373 |
Chapter 23 Absorption and Evaporation of Volatile Compounds Applied to Skin | 385 |
Chapter 24 Efficacy Absorption and Safety of Essential Oils | 401 |
Efficacy Skin Penetration and Toxicological Aspects | 419 |
Safety Considerations | 437 |
Chapter 27 Safety Assessments Based on Exposure Skin Permeation and Toxicity Considerations | 453 |
Skin Assessment | 467 |
Chapter 9 Permeability Through Diseased and Damaged Skin | 157 |
Chapter 10 Targeting the Pilosebaceous Gland | 169 |
Chapter 11 Drug Penetration Enhancement Through Human Nail and Skin | 189 |
Topical Pharmaceuticals Formulations and Indications | 197 |
Chapter 13 Drugs for Pain and Inflammation | 215 |
Chapter 14 Novel Topically Active Antimicrobial and Anti Antimicrobial and Antiinflammatory Compounds for Acne | 243 |
Potential Therapies for Dermatological Diseases | 255 |
Chapter 16 Topical Therapeutic Agents Used in Wound Care | 267 |
Chapter 17 Established and Emerging Oral Antifungals in Dermatology | 283 |
Chapter 18 Hydroxy Acids and Retinoids in Cosmetic Products | 297 |
Topical Cosmeceuticals Formulations and Indications | 303 |
Chapter 20 Influence of Formulation Design on the Clinical Performance of Topically Applied Formulations | 325 |
Chapter 29 Application of In Vivo Scanning Microscopy for Skin Analysis in Dermatology and Cosmetology | 487 |
Improving Therapeutic Outcomes Using Chemical Techniques | 497 |
Chapter 31 Multicomponent Formulations of Chemical Penetration Enhancers | 505 |
Improving Therapeutic Outcomes Using Physical Techniques | 517 |
Chapter 33 DNA Transfer in the Skin | 537 |
Chapter 34 Pressure Waves for Transdermal Drug Delivery | 557 |
Chapter 35 Microneedle Arrays as Transcutaneous Delivery Devices | 577 |
Chapter 36 NeedleFree Ballistic Delivery of Powdered Immunotherapeutics to the Skin Using Supersonic Gas Flow | 591 |
| 613 | |
Back cover | 629 |
Otras ediciones - Ver todo
Dermatological and Cosmeceutical Development: Absorption Efficacy and Toxicity Kenneth A. Walters,Michael S. Roberts No hay ninguna vista previa disponible - 2007 |
Términos y frases comunes
absorption acid activity agents amount application barrier body cause cells changes chemical clinical color compared compounds concentration containing cosmetic cream delivered delivery dermal Dermatol diffusion disease dose drug eczema effects efficacy enhancers epidermis et al evaluation exposure expression factors Figure formulation gene glucose hair human skin hydration important increase influence ingredient Invest Dermatol iontophoresis irritation keratinocytes lavender oil layers levels light lipid mean measured mechanisms melanin melanosomes membrane method microneedles molecules normal observed patients penetration percutaneous percutaneous absorption permeability permeation Pharm pigmentation potential properties protection proteins range recently reduced reported response showed shown significant solution stratum corneum structure studies suggested surface systemic Table TEWL therapy tion tissue topical topically applied transdermal transport treated treatment values vitamin vitro vivo wound
Pasajes populares
Página 1 - FDA) defines cosmetics as articles intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions.
Página 3 - L 262, p. 169) defines a cosmetic product as 'any substance or preparation intended for placing in contact with the various external parts of the human body (epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or principally to cleaning them, perfuming them or protecting them in order to keep them in good condition, change their appearance or correct body odours'.